aod9604 peptide fda AOD-9604 5mg Research AOD-9604 Vial (10mg) | High-Purity

Understanding DEA involvement helps clarify which peptides face additional restrictions beyond FDA oversight

It is supplied strictly for in-vitro laboratory research use only

The wall technique described earlier, angling the needle so water trickles down the glass before contacting powder, eliminates this impact damage

Recommended Injection Sites: Abdomen (2 inches from navel in any direction) Upper thighs (front or outer aspects) Upper arms (if administered by a partner) Rotate injection sites to prevent tissue irritation and lipohypertrophy Injection Supplies: 29-31 gauge insulin syringes (smaller gauge = less discomfort) 0.5-1ml syringe capacity 12.7mm (1/2 inch) needle length Alcohol swabs for site preparation Sharps container for safe needle disposal Injection Procedure: Wash hands thoroughly and prepare injection site with alcohol swab Allow alcohol to dry completely (prevents stinging) Pinch skin gently to create a fold of subcutaneous tissue Insert needle at 45-90 degree angle (depending on body fat thickness) Inject slowly and steadily over 5-10 seconds Withdraw needle and apply gentle pressure if needed Dispose of needle safely in sharps container Reconstitution Instructions 5-Amino-1MQ typically arrives as lyophilized (freeze-dried) powder requiring reconstitution before use

Description 5-Amino-1MQ 5mg Overview High-purity 5-amino-1mq peptide (5mg) formulated for advanced research applications, delivering consistent quality and reliable results in metabolic and cellular studies

It is a dual GLP-1 and GIP receptor agonist, meaning it activates two incretin hormone pathways simultaneously